Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bergenin tablets for acute exacerbation of COPD
ChiCTR2200055712Phase 4Recruiting
- Sponsor
- Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Guangzhou Medical University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Experimental arm: bergenin tablet with Control arm: placebo (2 arms). Primary endpoint: COPD Assessment Test (CAT) score. Started Jan 2021; status: recruiting.
02
Drugs
bergenin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2200055712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055712.